|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 6980 |
FusionGeneSummary for CHD3_PTPRF |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CHD3_PTPRF | Fusion gene ID: 6980 | Hgene | Tgene | Gene symbol | CHD3 | PTPRF | Gene ID | 1107 | 5792 |
| Gene name | chromodomain helicase DNA binding protein 3 | protein tyrosine phosphatase, receptor type F | |
| Synonyms | Mi-2a|Mi2-ALPHA|ZFH | BNAH2|LAR | |
| Cytomap | 17p13.1 | 1p34.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | chromodomain-helicase-DNA-binding protein 3ATP-dependent helicase CHD3CHD-3hZFHmi-2 autoantigen 240 kDa proteinzinc finger helicasezinc-finger helicase (Snf2-like) | receptor-type tyrosine-protein phosphatase FLCA-homologleukocyte antigen-related (LAR) PTP receptorleukocyte antigen-related tyrosine phosphataseleukocyte common antigen relatedprotein tyrosine phosphatase, receptor type, F polypeptidereceptor-linke | |
| Modification date | 20180522 | 20180522 | |
| UniProtAcc | Q12873 | P10586 | |
| Ensembl transtripts involved in fusion gene | ENST00000380358, ENST00000358181, ENST00000330494, ENST00000570758, | ENST00000359947, ENST00000438120, ENST00000372413, ENST00000372414, ENST00000422171, ENST00000496447, | |
| Fusion gene scores | * DoF score | 6 X 6 X 2=72 | 7 X 9 X 4=252 |
| # samples | 6 | 9 | |
| ** MAII score | log2(6/72*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/252*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CHD3 [Title/Abstract] AND PTPRF [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CHD3 | GO:0007051 | spindle organization | 17626165 |
| Hgene | CHD3 | GO:0007098 | centrosome cycle | 17626165 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF996711 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000380358 | ENST00000359947 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000380358 | ENST00000438120 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000380358 | ENST00000372413 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000380358 | ENST00000372414 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000380358 | ENST00000422171 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000380358 | ENST00000496447 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000359947 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000438120 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000372413 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000372414 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000422171 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000358181 | ENST00000496447 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000359947 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000438120 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000372413 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000372414 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000422171 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| 5CDS-intron | ENST00000330494 | ENST00000496447 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000359947 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000438120 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000372413 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000372414 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000422171 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
| intron-intron | ENST00000570758 | ENST00000496447 | CHD3 | chr17 | 7803997 | - | PTPRF | chr1 | 44065089 | + |
Top |
FusionProtFeatures for CHD3_PTPRF |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CHD3 | PTPRF |
| Component of the histone deacetylase NuRD complex whichparticipates in the remodeling of chromatin by deacetylatinghistones. Required for anchoring centrosomal pericentrin in bothinterphase and mitosis, for spindle organization and centrosomeintegrity. {ECO:0000269|PubMed:17626165,ECO:0000269|PubMed:9804427}. | Possible cell adhesion receptor. It possesses anintrinsic protein tyrosine phosphatase activity (PTPase) anddephosphorylates EPHA2 regulating its activity. The first PTPase domain has enzymatic activity, whilethe second one seems to affect the substrate specificity of thefirst one. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHD3_PTPRF |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHD3_PTPRF |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHD3_PTPRF |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHD3_PTPRF |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CHD3 | C0036920 | Sezary Syndrome | 1 | CTD_human |
| Tgene | PTPRF | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Tgene | PTPRF | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|